Abivax (AAVXF) Profit After Tax (2022 - 2026)

Abivax has reported Profit After Tax for 5 years, with the latest figure at $56.7 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 3.01% year-over-year to $56.7 million in Q1 2026; TTM through Mar 2026 was $386.2 million, a 145.24% increase from a year earlier, with the FY2025 full-year figure at $391.2 million, up 107.74% from the prior year.
• Profit After Tax was $56.7 million for Q1 2026 at Abivax, down from $95.4 million in the prior quarter.
• The five-year high for Profit After Tax was $179.3 million in Q3 2025, with the low at -$188.29 in Q4 2024.
• Average Profit After Tax over 5 years is $53.7 million, with a median of $54.8 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax sank 156.78% in 2023, then jumped 50670223.27% in 2025.
• Over 5 years, Profit After Tax stood at -$61.93 in 2022, then tumbled by 156.78% to -$159.02 in 2023, then declined by 18.4% to -$188.29 in 2024, then soared by 50670223.27% to $95.4 million in 2025, then slumped by 40.52% to $56.7 million in 2026.
• The last three Profit After Tax figures came in at $56.7 million (Q1 2026), $95.4 million (Q4 2025), and $179.3 million (Q3 2025), per Business Quant data.